N-(3,5-Dichlorophenyl)-2,2,2-trifluoroacetamide, 98%, 1g

4-(4-(1-Hydroxyethyl)-2-methoxy-5-nitrophenoxy)butanoic acid, 95.0%, 10g

GC capillary column ROTI®Cap-1701, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

5,7-DIPHENYLPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID, 95%, 250mg

N-Oxalylglycine, 98%, 5g

diethyl 2-acetamido-2-(4-(1,3-dioxoisoindolin-2-yl)-3-hydroxybutyl)malonate, 95+%, 2g

Ethyl 3-chloro-6-cyanopicolinate, 97%, 5g

L-Phenylephrine>98.0%(HPLC)(T)5g

5-Ethyl-2-methyl-nicotinic acid ethyl ester, 95.0%, 1g

2,5-Dibromo-1,1-dimethyl-3,4-diphenylsilole>98.0%(GC)1g

Diethyl 1-(2,4-dichlorophenyl)-5-methyl-4,5-dihydro-1H-pyrazole-3,5-dicarboxylate, 95.0%, 25g

4-Amino-6-chloro-5-methoxypyrimidine, 95.0%, 10g

2-Benzamido-4-methylpentanoic acid, 95.0%, 25g